1 UC San Diego School of Medicine, La Jolla, CA, USA.
2 Department of Surgery, Division of Vascular and Endovascular Surgery, UC San Diego, San Diego, CA, USA.
Vasc Med. 2018 Oct;23(5):467-475. doi: 10.1177/1358863X18789783. Epub 2018 Aug 13.
The primary objectives of this work were: (1) to describe trends in HIV prevalence among those undergoing carotid intervention (carotid endarterectomy or carotid artery stenting) in the United States; and (2) to determine if HIV infection is independently associated with symptomatic carotid atherosclerotic disease or age at the time of carotid intervention. In a nationally representative inpatient database from 2004 to 2014, HIV infection was associated with younger age at the time of carotid intervention (59 years [SE 0.2] vs 71 years [SE 0.01], p < 0.001), male sex (83% vs 58%, p < 0.001), black race (21% vs 4%, p < 0.001), and symptomatic carotid atherosclerotic disease (18.8% vs 11.0%, p < 0.001). Among those undergoing carotid intervention, there was a significant increase in the prevalence of HIV from 0.08% in 2004 to 0.17% in 2014 ( p < 0.001). After adjustment for patient demographics, comorbidities and other covariates, HIV infection remained significantly associated with younger age (-8.9 years; 95% CI: -9.7 to -8.1; p < 0.001) at the time of carotid intervention, but HIV infection was not independently associated with symptomatic carotid atherosclerotic disease.
(1) 描述美国接受颈动脉介入治疗(颈动脉内膜切除术或颈动脉支架置入术)的人群中 HIV 流行率的趋势;(2) 确定 HIV 感染是否与有症状的颈动脉粥样硬化疾病或颈动脉介入治疗时的年龄独立相关。在 2004 年至 2014 年期间的一项全国代表性住院患者数据库中,HIV 感染与颈动脉介入治疗时的年龄较小(59 岁[SE 0.2]与 71 岁[SE 0.01],p < 0.001)、男性(83%与 58%,p < 0.001)、黑种人(21%与 4%,p < 0.001)和有症状的颈动脉粥样硬化疾病(18.8%与 11.0%,p < 0.001)相关。在接受颈动脉介入治疗的患者中,HIV 的患病率从 2004 年的 0.08%显著增加到 2014 年的 0.17%(p < 0.001)。在调整患者人口统计学、合并症和其他协变量后,HIV 感染与颈动脉介入治疗时的年龄较小(-8.9 岁;95%CI:-9.7 至-8.1;p < 0.001)仍然显著相关,但 HIV 感染与有症状的颈动脉粥样硬化疾病无关。